197 related articles for article (PubMed ID: 24859929)
1. Overexpression of the muscle-specific protein, melusin, protects from cardiac ischemia/reperfusion injury.
Penna C; Brancaccio M; Tullio F; Rubinetto C; Perrelli MG; Angotti C; Pagliaro P; Tarone G
Basic Res Cardiol; 2014 Jul; 109(4):418. PubMed ID: 24859929
[TBL] [Abstract][Full Text] [Related]
2. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
[TBL] [Abstract][Full Text] [Related]
3. Aldose reductase modulates cardiac glycogen synthase kinase-3β phosphorylation during ischemia-reperfusion.
Abdillahi M; Ananthakrishnan R; Vedantham S; Shang L; Zhu Z; Rosario R; Zirpoli H; Bohren KM; Gabbay KH; Ramasamy R
Am J Physiol Heart Circ Physiol; 2012 Aug; 303(3):H297-308. PubMed ID: 22661511
[TBL] [Abstract][Full Text] [Related]
4. Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload.
De Acetis M; Notte A; Accornero F; Selvetella G; Brancaccio M; Vecchione C; Sbroggiò M; Collino F; Pacchioni B; Lanfranchi G; Aretini A; Ferretti R; Maffei A; Altruda F; Silengo L; Tarone G; Lembo G
Circ Res; 2005 May; 96(10):1087-94. PubMed ID: 15860758
[TBL] [Abstract][Full Text] [Related]
5. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
Sánchez JA; Rodríguez-Sinovas A; Barba I; Miró-Casas E; Fernández-Sanz C; Ruiz-Meana M; Alburquerque-Béjar JJ; García-Dorado D
Basic Res Cardiol; 2013 May; 108(3):351. PubMed ID: 23595215
[TBL] [Abstract][Full Text] [Related]
6. Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway.
Lacerda L; Somers S; Opie LH; Lecour S
Cardiovasc Res; 2009 Nov; 84(2):201-8. PubMed ID: 19666677
[TBL] [Abstract][Full Text] [Related]
7. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
[TBL] [Abstract][Full Text] [Related]
8. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
Ha T; Hu Y; Liu L; Lu C; McMullen JR; Kelley J; Kao RL; Williams DL; Gao X; Li C
Cardiovasc Res; 2010 Sep; 87(4):694-703. PubMed ID: 20421349
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.
Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS
Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030
[TBL] [Abstract][Full Text] [Related]
10. rAAV9-Mediated MEK1 Gene Expression Restores Post-conditioning Protection Against Ischemia Injury in Hypertrophic Myocardium.
Chen Y; Liu F; Chen BD; Li XM; Huang Y; Yu ZX; Gao XL; He CH; Yang YN; Ma YT; Gao XM
Cardiovasc Drugs Ther; 2020 Feb; 34(1):3-14. PubMed ID: 32103377
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism.
Ha T; Hua F; Liu X; Ma J; McMullen JR; Shioi T; Izumo S; Kelley J; Gao X; Browder W; Williams DL; Kao RL; Li C
Cardiovasc Res; 2008 Jun; 78(3):546-53. PubMed ID: 18267957
[TBL] [Abstract][Full Text] [Related]
12. Cardiac vulnerability to ischemia/reperfusion injury drastically increases in late pregnancy.
Li J; Umar S; Iorga A; Youn JY; Wang Y; Regitz-Zagrosek V; Cai H; Eghbali M
Basic Res Cardiol; 2012 Jul; 107(4):271. PubMed ID: 22648276
[TBL] [Abstract][Full Text] [Related]
13. Effect of pressure overload on cardioprotection via PI3K-Akt: comparison of postconditioning, insulin, and pressure unloading.
Mozaffari MS; Liu JY; Schaffer SW
Am J Hypertens; 2010 Jun; 23(6):668-74. PubMed ID: 20300072
[TBL] [Abstract][Full Text] [Related]
14. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
[TBL] [Abstract][Full Text] [Related]
15. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium.
Hamid SA; Bower HS; Baxter GF
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2598-606. PubMed ID: 17220176
[TBL] [Abstract][Full Text] [Related]
16. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
[TBL] [Abstract][Full Text] [Related]
17. Insulin and GSK3β-inhibition abrogates the infarct sparing-effect of ischemic postconditioning in ex vivo rat hearts.
Helgeland E; Wergeland A; Sandøy RM; Askeland M; Aspevik A; Breivik L; Jonassen AK
Scand Cardiovasc J; 2017 Jun; 51(3):159-166. PubMed ID: 28276718
[TBL] [Abstract][Full Text] [Related]
18. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion.
Hausenloy DJ; Tsang A; Mocanu MM; Yellon DM
Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H971-6. PubMed ID: 15358610
[TBL] [Abstract][Full Text] [Related]
19. Melusin protects from cardiac rupture and improves functional remodelling after myocardial infarction.
Unsöld B; Kaul A; Sbroggiò M; Schubert C; Regitz-Zagrosek V; Brancaccio M; Damilano F; Hirsch E; Van Bilsen M; Munts C; Sipido K; Bito V; Detre E; Wagner NM; Schäfer K; Seidler T; Vogt J; Neef S; Bleckmann A; Maier LS; Balligand JL; Bouzin C; Ventura-Clapier R; Garnier A; Eschenhagen T; El-Armouche A; Knöll R; Tarone G; Hasenfuß G
Cardiovasc Res; 2014 Jan; 101(1):97-107. PubMed ID: 24130190
[TBL] [Abstract][Full Text] [Related]
20. Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection.
Xu Y; Ma LL; Zhou C; Zhang FJ; Kong FJ; Wang WN; Qian LB; Wang CC; Liu XB; Yan M; Wang JA
PLoS One; 2013; 8(10):e76652. PubMed ID: 24124583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
